Literature DB >> 649727

Quantitative assay of rifampicin and three of its metabolites in human plasma, urine and saliva by high-performance liquid chromatography.

J B Lecaillon, N Febvre, J P Metayer, C Souppart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 649727     DOI: 10.1016/s0378-4347(00)81356-0

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  10 in total

1.  Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients.

Authors:  M H Chandler; S M Toler; R P Rapp; R R Muder; J A Korvick
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

2.  A sensitive method for quantitation of rifabutin and its desacetyl metabolite in human biological fluids by high-performance liquid chromatography (HPLC).

Authors:  R C Lewis; N Z Hatfield; P K Narang
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

3.  Rifampin blood and tissue levels in patients undergoing cardiac valve surgery.

Authors:  G L Archer; B C Armstrong; B J Kline
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

4.  Pharmacokinetics of oral and intravenous rifampicin during chronic administration.

Authors:  U Loos; E Musch; J C Jensen; G Mikus; H K Schwabe; M Eichelbaum
Journal:  Klin Wochenschr       Date:  1985-12-02

5.  Plasma rifampicin assay by an improved solvent extraction technique.

Authors:  J B McConnell; H Smith; M Davis; R Williams
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

6.  Bioequivalence study of two pharmaceutical forms of rifampicin capsules in man.

Authors:  N Chouchane; J Barre; A Toumi; J P Tillement; A Benakis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Oct-Dec       Impact factor: 2.441

Review 7.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

8.  Slow release formulations of inhaled rifampin.

Authors:  Intira Coowanitwong; Vikram Arya; Poj Kulvanich; Günther Hochhaus
Journal:  AAPS J       Date:  2008-06-27       Impact factor: 4.009

9.  A case of fatal poisoning by rifampicin.

Authors:  T A Plomp; H J Battista; H Unterdorfer; W C van Ditmarsch; R A Maes
Journal:  Arch Toxicol       Date:  1981-11       Impact factor: 5.153

Review 10.  Clinical pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.